AI Tool for Breast Cancer Diagnosis: Collaboration Between Clearview Diagnostics (now Koios Medical) and Dr. Susan Love Research Foundation
Note: Clearview Diagnostics is now Koios Medical, and the solution is Koios DS.
Clearview Diagnostics has developed artificial intelligence (AI) technology for breast cancer diagnosis using low-cost, portable ultrasound imaging devices.
This computer-aided diagnosis triage product (Clearview CADt) has the potential to save women’s lives in parts of the world that do not have access to routine breast cancer screening or diagnosis. This project is a collaborative effort with Dr. Susan Love and Dr. Susan Love Research Foundation (the Foundation) and is being funded by a $4 million grant from the National Institutes of Health (NIH), National Cancer Institute (NCI).